secwatch.observer — SEC 8-K summary
======================================

Issuer:     SRx Health Solutions, Inc. (SRXH)
CIK:        0001471727
Form:       8-K
Filed at:   2025-12-16T23:59:59+00:00
Accession:  0001493152-25-027898
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.80
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SRx Health to acquire EMJX in all-stock deal valued at ~$55M; Eric Jackson to become CEO and Chairman
--------------------------------------------------------------------------------

- Aggregate purchase price ~$55M payable in stock; transaction unanimously approved by SRx Health Board.
- Closing expected Q1 2026; subject to SRx shareholder approval, SEC filings, listing approval, and other conditions.
- Upon closing, Eric M. Jackson (EMJX founder/CEO) to serve as CEO and Chairman of combined company; combined entity to operate under EMJX name.
- EMJX is a Gen2 digital-asset treasury platform using quantitative models and AI for multi-asset risk management; target is to reduce reliance on equity dilution.
- The IP asset includes an AI algorithm designed to outperform Bitcoin and Ethereum based on trading volatility.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1471727/000149315225027898/0001493152-25-027898-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1471727/000149315225027898/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-027898

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer